DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 35 filers reported holding DEXCOM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $74,023,428 | -37.5% | 23,718,000 | -43.3% | 0.88% | -37.3% |
| Q1 2023 | $118,448,880 | +2.3% | 41,855,000 | -0.2% | 1.40% | +16.9% |
| Q4 2022 | $115,732,415 | +46.6% | 41,955,000 | +5.1% | 1.20% | +40.8% |
| Q3 2022 | $78,927,000 | -19.7% | 39,933,000 | -25.1% | 0.85% | -13.5% |
| Q2 2022 | $98,244,000 | -45.9% | 53,308,000 | -8.6% | 0.98% | -44.4% |
| Q1 2022 | $181,503,000 | -5.0% | 58,308,000 | -0.3% | 1.77% | -0.4% |
| Q4 2021 | $191,043,000 | -22.9% | 58,469,000 | -21.5% | 1.78% | -16.9% |
| Q3 2021 | $247,919,000 | +37.1% | 74,469,000 | +7.2% | 2.14% | +55.4% |
| Q2 2021 | $180,830,000 | -21.6% | 69,469,000 | -33.5% | 1.38% | -29.4% |
| Q1 2021 | $230,745,000 | -3.0% | 104,469,000 | 0.0% | 1.95% | +11.7% |
| Q4 2020 | $237,888,000 | +12.0% | 104,469,000 | +24.7% | 1.75% | -7.4% |
| Q3 2020 | $212,319,000 | +1.1% | 83,757,000 | -0.7% | 1.89% | -10.5% |
| Q2 2020 | $209,920,000 | +387.4% | 84,384,000 | +240.1% | 2.11% | +237.4% |
| Q1 2020 | $43,066,000 | – | 24,811,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |